Home › Overweight
Pag-aaral pangklinika para sa Overweight na nagre-recruit sa U.S.
204 pag-aaral para sa Overweight ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- San Antonio, TX34 pag-aaral
- Houston, TX33 pag-aaral
- Chicago, IL27 pag-aaral
- Orlando, FL25 pag-aaral
- Miami, FL23 pag-aaral
- Las Vegas, NV22 pag-aaral
- Atlanta, GA21 pag-aaral
- Dallas, TX20 pag-aaral
- Washington, DC19 pag-aaral
- Austin, TX19 pag-aaral
- New York City, NY19 pag-aaral
- Jacksonville, FL18 pag-aaral
- Baltimore, MD17 pag-aaral
- Havelock, NC17 pag-aaral
- Birmingham, AL17 pag-aaral
- Charlotte, NC16 pag-aaral
- Concord, CA16 pag-aaral
- Cincinnati, OH15 pag-aaral
- Phoenix, AZ15 pag-aaral
- Louisville, KY15 pag-aaral
- Tucson, AZ15 pag-aaral
- Johns Creek, GA14 pag-aaral
- Los Angeles, CA14 pag-aaral
- St. Louis, MO14 pag-aaral
- Philadelphia, PA14 pag-aaral
- San Diego, CA13 pag-aaral
- Boston, MA13 pag-aaral
- Columbus, OH13 pag-aaral
- Indianapolis, IN13 pag-aaral
- Salt Lake City, UT13 pag-aaral
- Escondido, CA12 pag-aaral
- Greensboro, NC12 pag-aaral
- Grand Prairie, TX12 pag-aaral
- Honolulu, HI11 pag-aaral
- Rochester, NY11 pag-aaral
- Arlington, VA11 pag-aaral
- South Fulton, GA11 pag-aaral
- Wilmington, NC11 pag-aaral
- Baton Rouge, LA11 pag-aaral
- Nashville, TN10 pag-aaral
Ayos sa estado
- Alabama30 pag-aaral
- Arizona29 pag-aaral
- Arkansas6 pag-aaral
- California64 pag-aaral
- Colorado12 pag-aaral
- Connecticut16 pag-aaral
- District of Columbia7 pag-aaral
- Florida53 pag-aaral
- Georgia37 pag-aaral
- Hawaii11 pag-aaral
- Idaho19 pag-aaral
- Illinois37 pag-aaral
- Indiana16 pag-aaral
- Iowa9 pag-aaral
- Kansas27 pag-aaral
- Kentucky21 pag-aaral
- Louisiana24 pag-aaral
- Maryland37 pag-aaral
- Massachusetts25 pag-aaral
- Michigan19 pag-aaral
- Minnesota12 pag-aaral
- Mississippi11 pag-aaral
- Missouri32 pag-aaral
- Montana6 pag-aaral
- Nebraska7 pag-aaral
- Nevada23 pag-aaral
- New Hampshire4 pag-aaral
- New Jersey16 pag-aaral
- New Mexico4 pag-aaral
- New York45 pag-aaral
- North Carolina41 pag-aaral
- North Dakota8 pag-aaral
- Ohio36 pag-aaral
- Oklahoma18 pag-aaral
- Oregon13 pag-aaral
- Pennsylvania32 pag-aaral
- Rhode Island13 pag-aaral
- South Carolina34 pag-aaral
- South Dakota4 pag-aaral
- Tennessee25 pag-aaral
- Texas55 pag-aaral
- Utah22 pag-aaral
- Virginia33 pag-aaral
- Washington24 pag-aaral
- Wisconsin8 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07668414A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07595549A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Kababaihan · Na-update Set 28, 2026 · NCT03407079Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07399678Physical and Behavioral Traits of Overweight and Obese Adults
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00428987Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07837973Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07752979Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07594093A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07803744FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06724406A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Nagre-recruitPhase 3
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07369011A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589608CHOICE to AVOID or RESIST
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06521021Impact of Lean Pork on Endothelial Function in Perimenopause
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 55 · Kababaihan · Na-update Set 22, 2026 · NCT06976112Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.